Methionine Adenosyltransferase (MAT) Inhibitor

Methionine Adenosyltransferase (MAT) Inhibitors (25):

Cat. No.	Product Name	Effect	Purity

HY-108331

3-TYP	Inhibitor	99.96%
3-TYP is an inhibitor of SIRT3 (IC₅₀of 38 μM) and an inhibitor of Methionine Adenosyltransferase (MAT) 2 and Indoleamine 2,3-Dioxygenase (IDO). There may be many off-target sites for 3-TYP that need to be examined, such as NAD-dependent enzymes, including dehydrogenases.

HY-112130

AGI-24512	Inhibitor	99.59%
AGI-24512 is a potent methionine adenosyltransferase 2α (MAT2A) inhibitor, with an IC₅₀ of 8 nM. AGI-24512 triggers DNA damage response. AGI-24512 can block proliferation of MTAP-deleted cancer cells in vitro. AGI-24512 can be used for researching anticancer.

HY-169257

SCR-7952	Inhibitor	99.77%
SCR-7952 is a MAT2A inhibitor, with IC₅₀ of 18.7 nM. SCR-7952 can be used in anti-cancer research.

HY-170501

MAT2A-IN-18	Inhibitor
MAT2A-IN-18 (Compound 15) is an inhibitor for methionine adenosyltransferase 2A (MAT2A) with an IC₅₀≤50 nM.

HY-170906S

MAT2A-IN-23	Inhibitor
MAT2A-IN-23 (compound 39) is a MAT2A inhibitor, with an IC₅₀ of 4 nM. MAT2A-IN-23 inhibits SAM in the HCT-116 (MTAP^−/−) and in the HCT-116 WT cell line with IC₅₀s of 3 and 2 nM, respectively. MAT2A-IN-23 inhibits SDMA in the HCT-116 (MTAP^−/−) and in the HCT-116 WT cell line with IC₅₀s of 2 and >3000 nM, respectively. MAT2A-IN-23 inhibits HCT-116 (MTAP^−/−) cell proliferation with with an IC₅₀ of 47 nM.

HY-162353

AZ'9567	Inhibitor	99.21%
AZ9567 is a potent MAT2A inhibitor. AZ9567 exhibits antiproliferative activity against MTAP KO HCT116 cells with a pIC₅₀ of 8.9.

HY-162135

MAT2A-IN-14	Inhibitor
MAT2A-IN-14 (compound H3) is a MAT2A inhibitor, and generates reactive oxygen species after sonication to specifically degrade cellular MAT2A via rapid oxidative reactions. Combination of MAT2A-IN-14 and sonication induces 87% MAT2A depletion in human colon cancer cell.

HY-170500

MAT2A-IN-17	Inhibitor
MAT2A-IN-17 is a potent MAT2A inhibitor with an IC₅₀ < 100 nM. MAT2A-IN-17 can be used in the study of cancer.

HY-170503

MAT2A-IN-20	Inhibitor
MAT2A-IN-20 (Compound A49) is an inhibitor for methionine adenosyltransferase 2A (MAT2A) with an IC₅₀ ≤50 nM. MAT2A-IN-20 inhibits human UGT1A1 with an IC₅₀ of 28.45 μM. MAT2A-IN-20 exhibits antitumor in mouse models.

HY-144184

MAT2A-IN-6	Inhibitor
MAT2A-IN-6 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally elevated in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-6 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-6 has the potential for the potential for the research of cancer diseases (extracted from patent WO2021254529A1, compound 18).

HY-144185

MAT2A-IN-7	Inhibitor
MAT2A-IN-7 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally elevated in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-7 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-7 has the potential for the potential for the research of cancer diseases (extracted from patent WO2021254529A1, compound 24).

HY-170905S

MAT2A-IN-22	Inhibitor
MAT2A-IN-22 (Compound 29-1) is a BBB-penatrable and orally active MAT2A inhibitor with an IC₅₀ of 4 nM. MAT2A-IN-22 shows selectivity and inhibitory activity against MTAP-deficient cancer cell lines. MAT2A-IN-22 has anti-tumor effects.

HY-168445

MAT2A-IN-21	Inhibitor
MAT2A-IN-21 (compound 28) is a potent methionine adenosyltransferase 2A (MAT2A) inhibitor with an IC₅₀ of 49 nM. MAT2A-IN-21 selectivity inhibits MTAP-deficient cancer cells.

HY-170502

MAT2A-IN-19	Inhibitor
MAT2A-IN-19 (Compound I-3) is an inhibitor for methionine adenosyltransferase 2A (MAT2A) with an IC₅₀ of 32.93 nM.

HY-162010

MAT2A-IN-13	Inhibitor
MAT2A-IN-13 is a potent and orally active methionine adenosyltransferase 2A (MAT2A) inhibitor with a favorable pharmacokinetic profile. MAT2A-IN-13 shows in vivo potency in an HCT-116 MTAP-deleted xenograft model. MAT2A-IN-13 can be used for MTAP-Deleted tumors treatment research.

HY-173281

MAT2A-IN-24	Inhibitor
MAT2A-IN-24 (Compound 9) is an inhibitor of methionine adenosyltransferase 2a (MAT2a). The IC₅₀ value for the inhibition of MAT2a is 20 nM, and the IC₅₀ value for the antiproliferative activity against HAP1MTAP–/– cells is 10 nM. MAT2A-IN-24 can be used in the research field of tumor diseases associated with MTAP deficiency.

HY-144181

MAT2A-IN-5	Inhibitor
MAT2A-IN-5 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally elevated in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-5 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-5 has the potential for the potential for the research of cancer diseases (extracted from patent WO2021254529A1, compound 1).

HY-155149

MAT2A-IN-12	Inhibitor
MAT2A Allosteric inhibitor 2 is a potent and selective MAT2A allosteric inhibitor with an IC₅₀ of 5 nM. MAT2A Allosteric inhibitor 2 shows nanomolar activity (IC₅₀=5 μM) in the the proliferation assay (MTAP^-/- cell line).

HY-155148

MAT2A-IN-11	Inhibitor
MAT2A Allosteric inhibitor 1 (compound 5) is a MAT2A selective inhibitor of methionine adenosyltransferase (MAT) with an IC₅₀ of 6.8 nM.

HY-161298

MAT2A-IN-15	Inhibitor
MAT2A-IN-15 (compound 8) is an inhibitor of MAT2A.

Name
Email *

	Sorry, but the email address you supplied was invalid.